Guardion Health Sciences Statistics
Total Valuation
Guardion Health Sciences has a market cap or net worth of 4.35 million. The enterprise value is -10.48 million.
| Market Cap | 4.35M |
| Enterprise Value | -10.48M |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | Sep 24, 2024 |
Share Statistics
Guardion Health Sciences has 1.35 million shares outstanding. The number of shares has increased by 2.26% in one year.
| Shares Outstanding | 1.35M |
| Shares Change (YoY) | +2.26% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 9.62% |
| Owned by Institutions (%) | 22.21% |
| Float | 1.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| PB Ratio | 0.30 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.64 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.67 |
Financial Position
The company has a current ratio of 16.67
| Current Ratio | 16.67 |
| Quick Ratio | 16.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -50.26% and return on invested capital (ROIC) is -21.29%.
| Return on Equity (ROE) | -50.26% |
| Return on Assets (ROA) | -15.53% |
| Return on Capital (ROIC) | -21.29% |
| Revenue Per Employee | 1.36M |
| Profits Per Employee | 708,327 |
| Employee Count | 9 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 5.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.64% in the last 52 weeks. The beta is 0.71, so Guardion Health Sciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -48.64% |
| 50-Day Moving Average | 7.47 |
| 200-Day Moving Average | 8.36 |
| Relative Strength Index (RSI) | 25.76 |
| Average Volume (20 Days) | 35,828 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.12 |
Income Statement
In the last 12 months, Guardion Health Sciences had revenue of 12.23 million and earned 6.37 million in profits. Earnings per share was 4.99.
| Revenue | 12.23M |
| Gross Profit | 5.45M |
| Operating Income | -3.58M |
| Pretax Income | -5.28M |
| Net Income | 6.37M |
| EBITDA | -3.56M |
| EBIT | -3.58M |
| Earnings Per Share (EPS) | 4.99 |
Balance Sheet
| Cash & Cash Equivalents | 14.82M |
| Total Debt | n/a |
| Net Cash | 14.82M |
| Net Cash Per Share | 10.98 |
| Equity (Book Value) | 13.75M |
| Book Value Per Share | 10.71 |
| Working Capital | 14.37M |
Cash Flow
In the last 12 months, operating cash flow was -3.92 million and capital expenditures -1, giving a free cash flow of -3.92 million.
| Operating Cash Flow | -3.92M |
| Capital Expenditures | -1 |
| Free Cash Flow | -3.92M |
| FCF Per Share | -2.90 |
Margins
Gross margin is 44.56%, with operating and profit margins of -29.24% and 52.13%.
| Gross Margin | 44.56% |
| Operating Margin | -29.24% |
| Pretax Margin | -43.14% |
| Profit Margin | 52.13% |
| EBITDA Margin | -29.08% |
| EBIT Margin | -29.24% |
| FCF Margin | -32.05% |
Dividends & Yields
Guardion Health Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.26% |
| Shareholder Yield | -2.26% |
| Earnings Yield | 154.87% |
| FCF Yield | -90.16% |
Stock Splits
The last stock split was on January 9, 2023. It was a reverse split with a ratio of 0.02.
| Last Split Date | Jan 9, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
Guardion Health Sciences has an Altman Z-Score of -3.17. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.17 |
| Piotroski F-Score | n/a |